Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis

Kidney International

Volumn 66, Issue 1, 2004, Pages 288-294

  Bantis, Christos ^a   Heering, Peter J ^a   Aker, Sendogan ^a   Klein Vehne, Nicola ^a   Grabensee, Bernd ^a   Ivens, Katrin ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Focal segmental glomerulosclerosis; G 1082A polymorphism; Genetic polymorphism; IgA nephropathy; Interleukin 10

Indexed keywords

CREATININE; INTERLEUKIN 10;

ADULT; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EVALUATION; FEMALE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; FOLLOW UP; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULONEPHRITIS; HEALTH STATUS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KAPLAN MEIER METHOD; KIDNEY BIOPSY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CODING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEINURIA; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; VOLUNTEER;

EID: 3042808475     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00730.x     Document Type: Article

References (45)

1. SCHENA FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89:209-215, 1990
2. CAMERON JS: The enigma of focal segmental glomerulosclerosis. Kidney Int 50(Suppl 57): S119-S131, 1996
3. D'AMICO G: Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 36:227-237, 2000
4. SCHENA FP: For further investigations in IgA nephropathy the approach from phenotype to genotype is welcome. Clin Exp Immunol 127:399-401, 2002
5. CONLON PJ, BUTTERLY D, ALBERS F, et al: Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am J Kidney Dis 26:34-40, 1995
6. GHARAVI AG, YAN Y, SCOLARI F, et al: IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26:354-357, 2000
7. KESTILA M, LENKKERI U, MANNIKKO M, et al: Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582, 1998
8. BOUTE N, GRIBOUVAL O, ROSELLI S, et al: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349-354, 2000
9. ANDERS HJ, VIELHAUER V, SCHLONDORFF D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63:401-415, 2003
10. MOORE KW, DE WAAL MALEFYT R, COFFMAN RL, O'GARRA A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765, 2001
11. TURNER DM, WILLIAMS DM, SANKARAN D, et al: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1-8, 1997
12. TAGORE A, GONSALKORALE WM, PRAVICA V, et al: Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 54:386-390, 1999
13. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462, 1993
14. FLOEGE J, FEEHALLY J: IgA nephropathy: Recent developments. J Am Soc Nephrol 11:2395-2403, 2000
15. HARPER SJ, PRINGLE JH, WICKS AC, et al: Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int 45:836-844, 1994
16. HARPER SJ, ALLEN AC, PRINGLE JH, FEEHALLY J: Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 49:38-42, 1996
17. MESTECKY J, TOMANA M, CROWLEY-NOWICK PA, et al: Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172-182, 1993
18. NIEMIR ZI, STEIN H, NORONHA IL, et al: PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995
19. YOSHIOKA K, TAKEMURA T, MURAKAMI K, et al: In situ expression of cytokines in IgA nephritis. Kidney Int 44:825-833, 1993
20. WALDHERR R, NORONHA IL, NIEMIR Z, et al: Expression of cytokines and growth factors in human glomerulonephritides. Pediatr Nephrol 7:471-478, 1993
21. RISLER T, BRAUN N, BACH D, et al: The German Glomerulonephritis Therapy Study: 10 years of controlled randomized trials for the treatment of idiopathic glomerulonephritis. Kidney Blood Press Res 19:196-200, 1996
22. FLOEGE J: Evidence-based recommendations for immunosuppression in IgA nephropathy: Handle with caution. Nephrol Dial Transplant 18:241-245, 2003
23. BUEMI M, ALLEGRA A, CORICA F, et al: Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. Clin Pharmacol Ther 67:427-231, 2000
24. ALEXOPOULOS E, STANGOU M, PAPAGIANNI A, et al: Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 15:1348-1356, 2000
25. STREHLAU J, SCHACHTER AD, PAVLAKIS M, et al: Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. Kidney Int 61:90-95, 2002
26. DEVARAJAN P, SPITZER A: Towards a biological characterization of focal segmental glomerulosclerosis. Am J Kidney Dis 39:625-636, 2002
27. SURANYI MG, GUASCH A, HALL BM, MYERS BD: Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 21:251-159, 1993
28. FIORENTINO DF, BOND MW, MOSMANN TR: Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2095, 1989
29. DE FIJTER JW, DAHA MR, SCHROEIJERS WE, et al: Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy. Clin Exp Immunol 111:429-434, 1998
30. YANO N, ENDOH M, NOMOTO Y, et al: Phenotypic characterization of cytokine expression in patients with IgA nephropathy. J Clin Immunol 17:396-403, 1997
31. NIEMIR ZI, ONDRACEK M, DWORACKI G, et al: In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Dis 32:80-92, 1998
32. KITCHING AR, TIPPING PG, TIMOSHANKO JR, HOLDSWORTH SR: Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int 57:518-525, 2000
33. KITCHING AR, KATERELOS M, MUDGE SJ, et al: Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol 128:36-43, 2002
34. CHOI YK, KIM YJ, PARK HS, et al: Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney. Gene Ther 10:559-568, 2003
35. MATSUMOTO K: Spontaneous and lipopolysaccharide-stimulated secretion of cytokines by peripheral blood monocytes in IgA nephropathy is inhibited by interleukin-10. Nephron 73:305-309, 1996
36. KIM JM, BRANNAN CI, COPELAND NG, et al: Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 148:3618-3623, 1992
37. KUBE D, PLATZER C, VON KNETHEN A, et al: Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7:1-7, 1995
38. ROMANO-SPICA V, GEORGIOU P, SUZUKI H, et al: Role of ETS1 in IL-2 gene expression. J Immunol 154:2724-2732, 1995
39. HAJEER AH, LAZARUS M, TURNER D, et al: IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142-145, 1998
40. MURAKOZY G, GAEDE KI, RUPRECHT B, et al: Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. J Mol Med 79:665-670, 2001
41. SANKARAN D, ASDERAKIS A, ASHRAF S, et al: Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56:281-288, 1999
42. ASDERAKIS A, SANKARAN D, DYER P, et al: Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: The cytokine effect on transplantation. Transplantation 71:674-677, 2001
43. GIRNDT M, KAUL H, SESTER U, et al: Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949-955, 2002
44. FRANCHIMONT D, MARTENS H, HAGELSTEIN MT, et al: Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84:2834-2839, 1999
45. BLANCHO G, GIANELLO PR, LORF T, et al: Molecular and cellular events implicated in local tolerance to kidney allografts in miniature swine. Transplantation 63:26-33, 1997